Evidence map›Paper›PMID 42583475›Full record

ArticleAnnals of medicine and surgery (2012)2026

Early metastatic

Hao Wang, Yu-Wei Xu, Xi-Long Pan, Hong-Hong Zhu

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hao WangDepartment of Surgery, Quzhou Hospital of Traditional Chinese Medicine, Quzhou, Zhejiang, P. R. China.
Yu-Wei XuDepartment of Surgery, Quzhou Hospital of Traditional Chinese Medicine, Quzhou, Zhejiang, P. R. China.
Xi-Long PanDepartment of Social Medicine and Health Education, School of Public Health, Peking University, Beijing, P. R. China.
Hong-Hong ZhuCenter for Medical Research, Quzhou Hospital of Traditional Chinese Medicine, Quzhou, Zhejiang, P. R. China.ORCID https://orcid.org/0000-0002-4300-6483

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and importance: Malignant melanoma (MM) has a poor prognosis and is rare in China. Case presentation: A 23-year-old man presented with an initial complaint of a mass under the left armpit without any symptoms. Multiple movable, merged, peanut-sized masses were found behind the left ear and a single peanut-sized mass in the left anterior chest and under the left armpit. These masses were medium-high in hardness upon palpation and were non-tender. Multiple black-brown flat moles, with diameters ranging from 2 to 4 mm, were observed on the anterior chest and abdomen; however, they did not meet any of the ABCD early diagnostic criteria for MM. Ultrasound revealed lymphadenopathy in the left neck and under the left armpit, with the mass under the left armpit subsequently excised. Histopathological results showed epithelioid cells with loosely arranged nuclei, melanin granules in the cytoplasm, and the following immunohistochemical markers: S-100 (+), HMB (partially+), Melan-A (+), SOX10 (+), P53 (locally+), and Discussion: It is rare to diagnose such an early metastatic Conclusion: Dabrafenib and Trametinib can be used as a standard of care for advanced

Indexed as

BRAFV600E mutationcase reportearly metastasisimmunohistochemical markersmelanomaPET/CT

Identifiers

PMID42583475
PMCPMC13460859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.